Lv11
30 积分 2022-11-10 加入
Comparison of agents using higher dose anti-VEGF therapy for treatment-resistant neovascular age-related macular degeneration
2小时前
已完结
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
4个月前
已完结
Faricimab Treat-and-Extend for Diabetic Macular Edema
4个月前
已完结
Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial
4个月前
已完结
KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema
4个月前
已完结
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema
4个月前
已完结
Efficacy of Intravitreal Injection of Aflibercept in Neovascular Age-Related Macular Degeneration With or Without Choroidal Vascular Hyperpermeability
6个月前
已完结
[Chinese expert consensus on the standardization of OCT and image interpretation and reporting in fundus diseases (2025): a Delphi approach]
6个月前
已完结
Efficacy and Treatment Burden of Intravitreal Aflibercept Versus Intravitreal Ranibizumab Treat-and-Extend Regimens at 2 Years: Network Meta-Analysis Incorporating Individual Patient Data Meta-Regression and Matching-Adjusted Indirect Comparison
6个月前
已完结
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
6个月前
已完结
皖公网安备34019202002308
